No Detail Found!

Synthesis and Characterization of C-3 Modified Gemifloxacin Derivatives as Potential Anti-Urease and Antimicrobial Agents

Author(s)
Sana Shamim Department of Pharmaceutical Chemistry, Dow College of Pharmacy, Faculty of Pharmaceutical Sciences, Dow University of Health Sciences, Ojha Campus Karachi-74200, Pakistan.
Ajmal Khan Natural and Medical Sciences Research Center, University of Nizwa, P.O. Box 33, Birkat Al Mauz, Nizwa 616, Oman.
Mahwish Akhtar Department of Pharmaceutical Chemistry, Dow College of Pharmacy, Faculty of Pharmaceutical Sciences, Dow University of Health Sciences, Ojha Campus Karachi-74200, Pakistan.
Nighat Shafi Department of Chemistry, Federal Urdu University of Arts, Science and Technology, Karachi Pakistan.
Tehseen Quds Department of Pharmacognosy, Dow College of Pharmacy, Faculty of Pharmaceutical Sciences, Dow University of Health Sciences, Ojha Campus Karachi-74200, Pakistan.
Sabahat Naeem Department of Pharmaceutical Chemistry, Dow College of Pharmacy, Faculty of Pharmaceutical Sciences, Dow University of Health Sciences, Ojha Campus Karachi-74200, Pakistan.
Rabya Munawar Department of Pharmaceutical Chemistry, Dow College of Pharmacy, Faculty of Pharmaceutical Sciences, Dow University of Health Sciences, Ojha Campus Karachi-74200, Pakistan.
Abstract
Background: Quinolones derivatives have been clinically effective and are used to treat bacterial infections in either community or hospital environments. In current circumstances, acquired microbial resistance (AMR) have gained profound interest for investigators due to irregular/ misuse of antibiotics. Objective: In order to overwhelm the resistance and increase the effectiveness, gemifloxacin-H2 receptor antagonist (cimetidine, famotidine and ranitidine) carboxamide derivatives were designed and synthesized by means of structural modifications at the C-3 position of gemifloxacin (GMFX), an important member of fluoroquinolone class. Method: Synthesis method allows incorporating number of substituents (cimetidine, famotidine and ranitidine)on carboxylic group of gemifloxacin present at position C-3. These synthesized derivatives were screened for their physicochemical properties and structurally characterized by spectroscopic analysis (UV-Vis, FT-IR, 1HNMR and Mass). Their in-vitro microbial activities (disk diffusion method) and anti-urease effectiveness were also determined. Results: Three new carboxamide derivatives (G-D21, G-D22 and G-D23) were synthesized in good yield. Spectroscopic studies reveals that the changes occurs at 1645-1639cm-1 attributed to ?(C=O) carb, which was originally observed at 1641-1633 cm-1 in gemifloxacin, indicating formation of amide bond. These derivatives didnot exhibit strong antibacterial response but G-D22 possess highest anti-urease activity (93.5%). Conclusion: Therefore, here we can conclude that these characterized carboxamide derivatives of gemifloxacin didn't exhibits microbial activities better than gemifloxacin against the studied organisms rather they were potent against the urease enzyme than the parent molecule.
Publication Details
Page(s) 31-39
DOI DOI not available
Published Journal: RADS Journal of Pharmacy and Allied Health Sciences, Volume: 2, Issue: 1, Year: 2024

Request the full text from PASTIC

Keywords
Antimicrobial activity, anti-urease, Spectroscopic, Gemifloxacin, H2 receptor antagonist
References
ANOVA . .ZI * indicates significance and -ve sign shows increase in activity.. df = 3, : 0.
Akunuri R,Veerareddy V,Kaul G,Akhir A,Unnissa T,Parupalli R,Madhavi YV,Chopra S,Nanduri S. Synthesis . .and antibacterial evaluation of (E)-1-(1H-indol-3-yl) ethanone O-benzyl oxime derivatives against MRSA and VRSA strains. 2021 Nov, 1 : 105288.
Prestinaci F,Pezzotti P,Pantosti A . .Antimicrobial resistance: a global multifaceted phenomenon. 2015 Oct, 3(7) : 309-18.
Cheung GY,Bae JS,Otto M. Pathogenicity . .and virulence of Staphylococcus aureus. Virulence. 2021 Dec, 31(1) : 547-69.
Abushaheen MA,Fatani AJ,Alosaimi M,Mansy W,George M,Acharya S,Rathod S,Divakar DD,Jhugroo C,Vellappally S,Khan AA . .Antimicrobial resistance, mechanisms and its clinical significance. 2020 Jun, 1(6) : 100971.
Zhao X,Zhao Y,Ren Z,Li Y. Combined QSAR . .QSPR and molecular docking study on fluoroquinolones to reduce biological enrichment. 2019 Apr, 1 : 177-84.
Pesson M,Antoine M,Chabassier S,Geiger S,Girard P,Richer D,lajudie P,Horvath E,Leriche B,Patte S. . .Antibacterial derivatives from 8-alkyl-5-oxo-5, 8 dihydro-pyrido [2, 3-d] pyrimidine-6 carboxylic-acids. 2. 2-piperazinyl and 2-(4-alkyl-piperazinyl) derivatives. 1974 Jan, 1(6) : 591-6.
Quan X,Du H,Xu J,Hou X,Gong X,Wu Y,Zhou Y,Jiang J,Lu L,Yuan S,Yang X . .Novel quinoline compound derivatives of NSC23925 as potent reversal agents against Pglycoprotein-mediated multidrug resistance. Frontiers in chemistry. 2019 Dec, 19 : 820.
Gilis PM,Haemers A,Bollaert W. .1980 .1H-Tetrazol5-yl derivatives of chemotherapeutic agents of the nalidixic acid type. European Journal of Medicinal Chemistry, 15(6) : 499-502.
Bush NG,Diez-Santos I,Abbott LR,Maxwell A . .Quinolones: mechanism, lethality and their contributions to antibiotic resistance. Molecules. 2020 Dec, 1(23) : 5662.
Matada BS,Pattanashettar R,Yernale NG . .A comprehensive review on the biological interest of quinoline and its derivatives. 2021 Feb, 15 : 115973.
Redgrave LS,Sutton SB,Webber MA,Piddock LJ . .Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success. Trends in microbiology. 2014 Aug, 1(8) : 438-45.
Jeelan Basha N,Basavarajaiah SM,Shyamsunder K. . .Therapeutic potential of pyrrole and pyrrolidine analogs: an update. Molecular Diversity, 26(5) : 2915-37.
Wakelin SH,Maibach HI,Archer CB . .Handbook of systemic drug treatment in dermatology. CRC Press; 2023 Feb, 13 : .
Thangam EB,Jemima EA,Singh H,Baig MS,Khan M,Mathias CB,Church MK,Saluja R .1873 .The role of histamine and histamine receptors in mast cell-mediated allergy and inflammation: the hunt for new therapeutic targets. 2018 Aug, 13 : .
Walesch S,Birkelbach J,Jézéquel G,Haeckl FJ,Hegemann JD,Hesterkamp T,Hirsch AK,Hammann P,Müller R . .Fighting antibiotic resistance-strategies and (pre) clinical developments to find new antibacterials. 2023 Jan, 9(1) : .
Pendlebury GA,Oro P,Ludlow K,Merideth D,Haynes W,Shrivastava V,Ludlow KS . .Relevant dermatoses among US military service members: an operational review of management strategies and telemedicine utilization. Cureus. 2023 Jan, 2(1) : .
Mohammed GF,Al‐Dhubaibi MS,Bahaj SS,Elneam AI .2022 .Systemic immunotherapy for the treatment of warts: A literature review. Journal of Cosmetic Dermatology, 21(11) : 5532-6.
Dickey AK,Naik H,Keel SB,Levy C,Beaven SW,Elmariah SB,Erwin AL,Goddu RJ,Hedstrom K,Leaf RK,Kazamel M. . .Evidencebased consensus guidelines for the diagnosis and management of erythropoietic protoporphyria and X-linked protoporphyria. Journal of the American Academy of Dermatology. 2022 Aug, 27 : .
Mitscher LA . .Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents. 2005 Feb, 9(2) : 559-92.
Turel I. . .The interactions of metal ions with quinolone antibacterial agents. 2002 Oct, 1(1-2) : 27-47.
Shariati A,Arshadi M,Khosrojerdi MA,Abedinzadeh M,Ganjalishahi M,Maleki A,Heidary M,Khoshnood S. . .The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic. 2022 Dec, 21 : 1025633.
Kim SH,Semenya D,Castagnolo D. . .Antimicrobial drugs bearing guanidine moieties: A review. 2021 Apr, 15 : 113293.
Ude Z,Flothkötter N,Sheehan G,Brennan M,Kavanagh K,Marmion CJ . .Multi-targeted metallo-ciprofloxacin derivatives rationally designed and developed to overcome antimicrobial resistance. International Journal of Antimicrobial Agents. 2021 Dec, 1(6) : 106449.
Akhtar M,Shamim S,Siddiqi TA,Sultana N,Arayne MS . .Synthesis and antimicrobial evaluation of unique 3-carboxamide derivatives of moxifloxacin with selected H2 inhibitor. International Journal of Biological and Pharmaceutical Applied Sciences. 2019 May;8, (5) : 968-980.
Begum I,Ameen F,Soomro Z,Shamim S,AlNadhari S,Almansob A,Al-Sabri A,Arif A . .Facile fabrication of malonic acid capped silver nanoparticles and their antibacterial activity. 2021 Jan, 1(1) : 101231.
Shamim S,Gul S,Rauf A,Rashid U,Khan A,Amin R . .Gemifloxacin-transition metal complexes as therapeutic candidates: antimicrobial, antifungal, anti-enzymatic, and docking studies of newly synthesized complexes. Heliyon. 2022 Aug, 1(8) : .
0

Citations

0

Downloads

6

Views